Evidence map›Paper›PMID 34350560›Full record

ArticleJournal of neuro-oncology2021

Type of bony involvement predicts genomic subgroup in sphenoid wing meningiomas.

Lan Jin, Mark W Youngblood, Trisha P Gupte, Shaurey Vetsa, Arushii Nadar, Tanyeri Barak, Kanat Yalcin, Stephanie M Aguilera, Ketu Mishra-Gorur, Nicholas A Blondin and 11 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Radiotherapy and radiosurgery for meningiomas.Neuro-oncology advances · 2023
    Article
  4. Review
  5. Review
  6. Cancers · 2022
    Article
  7. Article
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 1 country.

Lan Jin *Department of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.
Mark W Youngblood *Department of Neurological Surgery, Northwestern University, Chicago, IL, USA.
Trisha P GupteDepartment of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.
Shaurey VetsaDepartment of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.
Arushii NadarDepartment of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.
Tanyeri BarakDepartment of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.
Kanat YalcinDepartment of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.
Stephanie M AguileraDepartment of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.
Ketu Mishra-GorurDepartment of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.
Nicholas A BlondinYale Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
Evan GorelickDepartment of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.
S Bulent OmayDepartment of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.
Renelle Pointdujour-LimYale Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
Benjamin L JudsonYale Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
Michael AlperovichYale Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
Mariam S AboianYale Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
Declan McGuoneYale Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
Murat GunelDepartment of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.
Zeynep Erson-OmayDepartment of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA.
Robert K FulbrightYale Brain Tumor Center, Smilow Cancer Hospital, New Haven, CT, USA.
Jennifer MoliternoDepartment of Neurosurgery, Yale School of Medicine, 15 York St, LLCI 810, New Haven, CT, 06520-8082, USA. jennifermoliterno.gunel@yale.edu.ORCID http://orcid.org/0000-0002-6413-5874
Yale University · USNorthwestern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAs sphenoid wing meningiomas (SWMs) are associated with varying degrees of bony involvement, we sought to understand potential relationships between genomic subgroup and this feature.

methodsPatients treated at Yale-New Haven Hospital for SWM were reviewed. Genomic subgroup was determined via whole exome sequencing, while the extent of bony involvement was radiographically classified as no bone invasion (Type I), hyperostosis only (Type II), tumor invasion only (Type III), or both hyperostosis and tumor invasion (Type IV). Among additional clinical variables collected, a subset of tumors was identified as spheno-orbital meningiomas (SOMs). Machine-learning approaches were used to predict genomic subgroups based on pre-operative clinical features.

resultsAmong 64 SWMs, 53% had Type-II, 9% had Type-III, and 14% had Type-IV bone involvement; nine SOMs were identified. Tumors with invasion (i.e., Type III or IV) were more likely to be WHO grade II (p: 0.028). Additionally, tumors with invasion were nearly 30 times more likely to harbor NF2 mutations (OR 27.6; p: 0.004), while hyperostosis only were over 4 times more likely to have a TRAF7 mutation (OR 4.5; p: 0.023). SOMs were a significant predictor of underlying TRAF7 mutation (OR 10.21; p: 0.004).

conclusionsSWMs with invasion into bone tend to be higher grade and are more likely to be NF2 mutated, while SOMs and those with hyperostosis are associated with TRAF7 variants. Pre-operative prediction of molecular subtypes based on radiographic bony characteristics may have significant biological and clinical implications based on known recurrence patterns associated with genomic drivers and grade.

Indexed as

HyperostosisMeningeal NeoplasmsMeningiomaGenomicsHumansTreatment OutcomeBone invasionGenomic subgroupsHyperostosisMeningioma

Identifiers

PMID34350560
OpenAlexW3190634085

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.